BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 12808168)

  • 1. Idiopathic minimal change nephrotic syndrome in older adults: steroid responsiveness and pattern of relapses.
    Tse KC; Lam MF; Yip PS; Li FK; Choy BY; Lai KN; Chan TM
    Nephrol Dial Transplant; 2003 Jul; 18(7):1316-20. PubMed ID: 12808168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Clinical Course of Minimal Change Nephrotic Syndrome With Onset in Adulthood or Late Adolescence: A Case Series.
    Maas RJ; Deegens JK; Beukhof JR; Reichert LJ; Ten Dam MA; Beutler JJ; van den Wall Bake AWL; Rensma PL; Konings CJ; Geerse DA; Feith GW; Van Kuijk WH; Wetzels JF
    Am J Kidney Dis; 2017 May; 69(5):637-646. PubMed ID: 28089478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steroid responsiveness and frequency of relapse in adult-onset minimal change nephrotic syndrome.
    Nakayama M; Katafuchi R; Yanase T; Ikeda K; Tanaka H; Fujimi S
    Am J Kidney Dis; 2002 Mar; 39(3):503-12. PubMed ID: 11877569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcome of biopsy-proven minimal change nephropathy in Chinese adults.
    Szeto CC; Lai FM; Chow KM; Kwan BC; Kwong VW; Leung CB; Li PK
    Am J Kidney Dis; 2015 May; 65(5):710-8. PubMed ID: 25465164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical characteristics of adult-onset minimal change nephrotic syndrome in our hospital].
    Mori D; Shinzawa M; Namba T; Yamaguchi Y; Itano S; Imakita N; Matsuda J; Murata H; Takeji M; Yamamoto R; Isaka Y; Yamauchi A
    Nihon Jinzo Gakkai Shi; 2012; 54(7):1023-30. PubMed ID: 23234214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimal change nephrotic syndrome in children with intrauterine growth retardation.
    Sheu JN; Chen JH
    Am J Kidney Dis; 2001 May; 37(5):909-14. PubMed ID: 11325671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimal change nephrotic syndrome in adults: response to corticosteroid therapy and frequency of relapse.
    Fujimoto S; Yamamoto Y; Hisanaga S; Morita S; Eto T; Tanaka K
    Am J Kidney Dis; 1991 Jun; 17(6):687-92. PubMed ID: 2042651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of single-dose rituximab on steroid-dependent minimal-change nephrotic syndrome in adults.
    Takei T; Itabashi M; Moriyama T; Kojima C; Shiohira S; Shimizu A; Tsuruta Y; Ochi A; Amemiya N; Mochizuki T; Uchida K; Tsuchiya K; Nitta K
    Nephrol Dial Transplant; 2013 May; 28(5):1225-32. PubMed ID: 23239834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Long-term follow-up study of children with minimal change nephrotic syndrome].
    Takeichi S; Tazawa M; Morooka M; Minowa S; Yasaki T
    Nihon Jinzo Gakkai Shi; 1997 Mar; 39(2):155-60. PubMed ID: 9134833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized, Controlled Trial of Tacrolimus and Prednisolone Monotherapy for Adults with
    Medjeral-Thomas NR; Lawrence C; Condon M; Sood B; Warwicker P; Brown H; Pattison J; Bhandari S; Barratt J; Turner N; Cook HT; Levy JB; Lightstone L; Pusey C; Galliford J; Cairns TD; Griffith M
    Clin J Am Soc Nephrol; 2020 Feb; 15(2):209-218. PubMed ID: 31953303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tacrolimus as a steroid-sparing agent for adults with steroid-dependent minimal change nephrotic syndrome.
    Li X; Li H; Chen J; He Q; Lv R; Lin W; Li Q; He X; Qu L; Suya W
    Nephrol Dial Transplant; 2008 Jun; 23(6):1919-25. PubMed ID: 17911091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rituximab for minimal-change nephrotic syndrome in adulthood: predictive factors for response, long-term outcomes and tolerance.
    Guitard J; Hebral AL; Fakhouri F; Joly D; Daugas E; Rivalan J; Guigonis V; Ducret F; Presne C; Pirson Y; Hourmant M; Glachant JC; Vendrely B; Moranne O; Faguer S; Chauveau D
    Nephrol Dial Transplant; 2014 Nov; 29(11):2084-91. PubMed ID: 24920841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the Efficacy and Safety of Tacrolimus and Low-Dose Corticosteroid with High-Dose Corticosteroid for Minimal Change Nephrotic Syndrome in Adults.
    Chin HJ; Chae DW; Kim YC; An WS; Ihm C; Jin DC; Kim SG; Kim YL; Kim YS; Kim YG; Koo HS; Lee JE; Lee KW; Oh J; Park JH; Jiang H; Lee H; Lee SK
    J Am Soc Nephrol; 2021 Jan; 32(1):199-210. PubMed ID: 33168602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial effect of chlorambucil in steroid-dependent and cyclophosphamide-resistant minimal change nephrotic syndrome.
    Ueda N; Takahashi K; Akioka Y; Morooka M; Ogawa A; Tsuzuki K
    J Nephrol; 2009; 22(5):610-5. PubMed ID: 19809993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The long-term outlook to final outcome and steroid treatment results in children with idiopathic nephrotic syndrome.
    Dinçel N; Yılmaz E; Kaplan Bulut İ; Hacıkara Ş; Mir S
    Ren Fail; 2015; 37(8):1267-72. PubMed ID: 26313331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term clinical and pathological effects of cyclosporin in children with nephrosis.
    Seikaly MG; Prashner H; Nolde-Hurlbert B; Browne R
    Pediatr Nephrol; 2000 Mar; 14(3):214-7. PubMed ID: 10752760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effects of intravenous methylprednisolone pulse versus oral prednisolone therapies on the first attack of minimal-change nephrotic syndrome in adults.
    Fukudome K; Fujimoto S; Sato Y; Kitamura K
    Nephrology (Carlton); 2012 Mar; 17(3):263-8. PubMed ID: 22117558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined cyclosporine and prednisolone therapy using cyclosporine blood concentration monitoring for adult patients with new-onset minimal change nephrotic syndrome: a single-center pilot randomized trial.
    Shirai S; Imai N; Sueki S; Matsui K; Tominaga N; Sakurada T; Yasuda T; Kimura K; Shibagaki Y
    Clin Exp Nephrol; 2018 Apr; 22(2):283-290. PubMed ID: 28699032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimal-change nephrotic syndrome in adults treated with alternate-day steroids.
    Nair RB; Date A; Kirubakaran MG; Shastry JC
    Nephron; 1987; 47(3):209-10. PubMed ID: 3683690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case of high-age minimal change nephrotic syndrome relapse after 18-year remission and effective treatment with steroid and cyclosporin combined therapy].
    Yoshimoto K; Wada T; Iwata Y; Sakai N; Shimizu M; Furuichi K; Yokoyama H; Kobayashi K
    Nihon Jinzo Gakkai Shi; 2000 Oct; 42(8):640-3. PubMed ID: 11195400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.